VERTEX PHARMACEUTICALS INC / MA — SC 13G/A Filings
122 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by VERTEX PHARMACEUTICALS INC / MA (VRTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. VERTEX PHARMACEUTICALS INC / MA has filed 122 SC 13G/A documents with the SEC since 2020. To view all SEC filings by VERTEX PHARMACEUTICALS INC / MA, see the full filings list.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B2
424B3
424B5
425
5
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PX14A6G
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SEC SCHEDULE 13G | 0001422849-24-000023 | Apr 10, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022233 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001554 | Feb 9, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422848-24-000255 | Feb 9, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-017239 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000080255-22-001976 | Feb 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018841 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000315066-22-001241 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000834237-22-004423 | Feb 1, 2022 | — |
| SC 13G/A | — | 0000080255-21-001070 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-019362 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-001338 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000834237-21-005618 | Feb 1, 2021 | — |
| SC 13G/A | — | 0000080255-20-001093 | Feb 14, 2020 | — |
| SC 13G/A | SCHEDULE 13 G/A - AMENDMENT 1 | 0001341004-20-000055 | Feb 13, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018398 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000315066-20-001299 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000834237-20-006904 | Feb 6, 2020 | — |
| SC 13G/A | — | 0000080255-19-002473 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000315066-19-001425 | Feb 13, 2019 | — |
| SC 13G/A | — | 0000932471-19-004861 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000215457-19-005760 | Feb 6, 2019 | — |
| SC 13G/A | — | 0000080255-18-002365 | Feb 14, 2018 | — |
| SC 13G/A | — | 0000315066-18-001672 | Feb 13, 2018 | — |
| SC 13G/A | — | 0000932471-18-004219 | Feb 9, 2018 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-18-000215 | Feb 8, 2018 | — |
| SC 13G/A | — | 0000932471-18-000700 | Feb 2, 2018 | — |
| SC 13G/A | — | 0000215457-18-002300 | Jan 23, 2018 | — |
| SC 13G/A | SC 13G/A | 0001422849-17-000166 | Dec 11, 2017 | — |
| SC 13G/A | VRTX AS OF 07/31/2017 | 0000080255-17-001358 | Aug 10, 2017 | — |
| SC 13G/A | — | 0000315066-17-002123 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001422849-17-000131 | Feb 13, 2017 | — |
| SC 13G/A | — | 0000932471-17-002234 | Feb 10, 2017 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-17-000410 | Feb 9, 2017 | — |
| SC 13G/A | — | 0000080255-17-001238 | Feb 7, 2017 | — |
| SC 13G/A | — | 0000215457-17-001846 | Jan 27, 2017 | — |
| SC 13G/A | VRTX AS OF 02/29/2016 | 0000080255-16-001224 | Mar 10, 2016 | — |
| SC 13G/A | SC 13G/A | 0001422849-16-000686 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000315066-16-005580 | Feb 12, 2016 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-16-001092 | Feb 11, 2016 | — |
| SC 13G/A | — | 0000932471-16-012014 | Feb 11, 2016 | — |
| SC 13G/A | VRTX AS OF 12/31/2015 | 0000080255-16-001041 | Feb 11, 2016 | — |
| SC 13G/A | — | 0000215457-16-005805 | Feb 10, 2016 | — |
| SC 13G/A | SC 13G/A | 0001422849-15-000303 | Feb 13, 2015 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-15-000465 | Feb 12, 2015 | — |
| SC 13G/A | — | 0000932471-15-004878 | Feb 11, 2015 | — |
| SC 13G/A | 13G FINAL ANNUAL FILING - VRTX | 0000053417-15-000135 | Feb 10, 2015 | — |
| SC 13G/A | — | 0001137774-15-000056 | Feb 2, 2015 | — |
| SC 13G/A | — | 0001086364-15-000609 | Jan 22, 2015 | — |
| SC 13G/A | SC 13G/A | 0001422849-14-000269 | Feb 13, 2014 | — |